Form D · Biotechnology

VEDANTA BIOSCIENCES, INC.

Cambridge, MA · CIK 0001677878

Offering snapshot reported Aug 5, 2024 · SEC filing

Reported sold
$119M
Offering amount: $119M
Investors reported
25
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 1, 2023
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$59.3M$119MMay 2, 2023: $106,500,000.00May 2, 2023Aug 5, 2024: $118,500,000.00Aug 5, 2024

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$106,500,000 → $118,500,000
  • Reported investors22 → 25

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 5, 2024Amendment$118,500,000$12,000,000vs May 2, 202325SEC filing
May 2, 2023Initial$106,500,000No comparison22SEC filing
Aug 13, 2021Initial$68,406,915No comparison18SEC filing
Sep 19, 2019Initial$7,999,939No comparison4SEC filing
May 8, 2019Amendment$45,394,519$5,500,236vs Mar 28, 201913SEC filing
Mar 28, 2019Amendment$39,894,283$13,167,600vs Feb 5, 201911SEC filing
Feb 5, 2019Initial$26,726,683No comparison8SEC filing

Offering details

Securities
Debt, Option to acquire
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$400K
Finders' fees
$0
Form D file number
021-480626

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
FJS Consultants LimitedNone

Source: Form D, filed Aug 5, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Bharatt Chowrira Director
Daniel Couto Executive
Susan Dillon Director
Martin Heidecker Director
Troy Ignelzi Director
Curt La Belle Director
John La Mattina Director
Mark Mullikin Executive
Bernat Olle Director, Executive
Bennett Shapiro Director
Charles Sherwood Director
Jeffrey Silber Executive
Neil Tiwari Director
Christopher Viehbacher Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
19 Blackstone Street
Cambridge, MA, 02139